• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-induced Liver Injury from Hormonal and Non-hormonal Therapies: Insights from a Large Case Series.

作者信息

Vuppalanchi Raj, Chalasani Naga

机构信息

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

出版信息

J Clin Exp Hepatol. 2024 May-Jun;14(3):101401. doi: 10.1016/j.jceh.2024.101401. Epub 2024 Mar 19.

DOI:10.1016/j.jceh.2024.101401
PMID:38596343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11000177/
Abstract
摘要

相似文献

1
Drug-induced Liver Injury from Hormonal and Non-hormonal Therapies: Insights from a Large Case Series.激素及非激素治疗所致药物性肝损伤：来自大型病例系列研究的见解
J Clin Exp Hepatol. 2024 May-Jun;14(3):101401. doi: 10.1016/j.jceh.2024.101401. Epub 2024 Mar 19.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 May 15;5(5):CD014908. doi: 10.1002/14651858.CD014908.pub3.
4
The Current Strategy in Hormonal and Non-Hormonal Therapies in Menopause-A Comprehensive Review.更年期激素与非激素疗法的当前策略——全面综述
Life (Basel). 2023 Feb 26;13(3):649. doi: 10.3390/life13030649.
5
First-choice hormonal therapies for children with infantile epileptic spasms syndrome in South Asia: A network meta-analysis of randomized controlled trials.南亚地区婴儿痉挛症综合征患儿的一线激素疗法：随机对照试验的网状Meta分析
Epilepsia Open. 2024 Dec;9(6):2037-2048. doi: 10.1002/epi4.13086. Epub 2024 Nov 8.
6
Hormonal contraceptive use among women with liver tumors: a systematic review.肝肿瘤女性使用激素避孕方法的系统评价。
Contraception. 2009 Oct;80(4):387-90. doi: 10.1016/j.contraception.2009.01.021. Epub 2009 Jun 10.
7
Drug-induced liver injury caused by the histrelin (Vantus) subcutaneous implant.组氨瑞林（Vantus）皮下植入剂所致药物性肝损伤。
South Med J. 2010 Jan;103(1):84-6. doi: 10.1097/SMJ.0b013e3181c376a6.
8
Toxin-Induced Liver Injury and Extracorporeal Treatment of Liver Failure.毒素诱导的肝损伤与肝衰竭的体外治疗。
Adv Kidney Dis Health. 2024 Mar;31(2):157-165. doi: 10.1053/j.akdh.2024.03.001.
9
Secondary hormonal therapy for advanced prostate cancer.晚期前列腺癌的二线激素治疗
J Urol. 2006 Jan;175(1):27-34. doi: 10.1016/S0022-5347(05)00034-0.
10
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis.子宫肉瘤、侵袭性血管黏液瘤和硬纤维瘤型纤维瘤病的激素治疗。
Crit Rev Oncol Hematol. 2019 Nov;143:62-66. doi: 10.1016/j.critrevonc.2019.08.007. Epub 2019 Aug 31.

本文引用的文献

1
Clinical Features, Laboratory Characteristics and Outcome from Oral Contraceptives-induced Liver Injury in 43 Consecutive Patients and a Brief Review of Published Reports.43例连续口服避孕药所致肝损伤患者的临床特征、实验室检查特点及预后，并对已发表报告进行简要综述
J Clin Exp Hepatol. 2024 May-Jun;14(3):101322. doi: 10.1016/j.jceh.2023.101322. Epub 2023 Dec 16.
2
Novel Advances in the Role of Selective Estrogen Receptor Modulators in Hormonal Replacement Therapy: A Paradigm Shift.选择性雌激素受体调节剂在激素替代疗法中作用的新进展：一种范式转变
Cureus. 2023 Nov 19;15(11):e49079. doi: 10.7759/cureus.49079. eCollection 2023 Nov.
3
A review of phase II and III drugs for the treatment and management of endometriosis.内异症治疗和管理的 II 期和 III 期药物研究综述。
Expert Opin Emerg Drugs. 2023 Dec;28(4):333-351. doi: 10.1080/14728214.2023.2296080. Epub 2023 Dec 26.
4
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.选择性雄激素受体调节剂的使用及相关不良事件，包括药物性肝损伤：疑似病例分析。
Eur J Clin Pharmacol. 2024 Feb;80(2):185-202. doi: 10.1007/s00228-023-03592-3. Epub 2023 Dec 7.
5
Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator.依诺博沙姆（一种选择性雄激素受体调节剂）继发的药物性肝损伤
J Med Cases. 2022 May;13(5):244-248. doi: 10.14740/jmc3937. Epub 2022 May 7.
6
Selective Androgen Receptor Modulator Induced Hepatotoxicity.选择性雄激素受体调节剂诱导的肝毒性。
Cureus. 2022 Feb 15;14(2):e22239. doi: 10.7759/cureus.22239. eCollection 2022 Feb.
7
Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up.醋酸乌利司他混悬液治疗后有症状的子宫肌瘤的管理和在随访 6 个月时识别手术的高危患者。
Gynecol Endocrinol. 2021 Sep;37(9):831-835. doi: 10.1080/09513590.2021.1929152. Epub 2021 May 28.
8
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.西班牙 DILI 登记处的长期经验带来的综合分析和见解。
J Hepatol. 2021 Jul;75(1):86-97. doi: 10.1016/j.jhep.2021.01.029. Epub 2021 Feb 1.
9
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.左炔诺孕酮用于紧急避孕的系统评价
Drug Saf. 2020 Dec;43(12):1277-1285. doi: 10.1007/s40264-020-00975-8.
10
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!乌利司他醋酸乙酯治疗子宫肌瘤的应用暂停：在 EMA 审查肝损伤风险期间恰逢新冠疫情！
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:300-302. doi: 10.1016/j.ejogrb.2020.06.064. Epub 2020 Jun 27.